Trividia

Trividia Health Issues Correction Notice for TRUE METRIX Blood Glucose Monitoring Systems

Updated Labeling Guidance and Safety Measures Address E-5 Error Code While Company Develops Long-Term Software Solution Trividia Health, Inc., a globally recognized leader in diabetes care and blood glucose monitoring solutions, has issued an updated communication regarding its previously announced…

Read MoreTrividia Health Issues Correction Notice for TRUE METRIX Blood Glucose Monitoring Systems
Jakafi

Jakafi XR Wins FDA Approval for Myelofibrosis, Polycythemia Vera, and GVHD Treatment

Incyte Secures FDA Approval for Jakafi XR™ (Ruxolitinib Extended-Release), Expanding Treatment Options for Patients with Blood Disorders and GVHD Incyte has announced that the U.S. Food and Drug Administration has granted approval to Jakafi XR™ (ruxolitinib), a once-daily extended-release oral…

Read MoreJakafi XR Wins FDA Approval for Myelofibrosis, Polycythemia Vera, and GVHD Treatment
FDA

FDA Panel Backs TRUQAP for PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer

ODAC Endorses TRUQAP Combination Therapy Based on Phase III CAPItello-281 Results Showing Improved Progression-Free Survival and Addressing Unmet Need The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC) has voted in favor of a new treatment approach involving…

Read MoreFDA Panel Backs TRUQAP for PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer
Canadian

Canadian Association of Optometrists Launches “GetEyeWise” Campaign for Vision Health Month

Canadian Association of Optometrists Launches “GetEyeWise” Campaign to Promote Vision Health Awareness If reading fine print has become a challenge, it may be time to “GetEyeWise.” That’s the message behind a nationwide public education campaign launched by the Canadian Association…

Read MoreCanadian Association of Optometrists Launches “GetEyeWise” Campaign for Vision Health Month
Cairn

Cairn Surgical Announces Positive Pivotal Trial Results for Breast Cancer Locator System

Cairn Surgical, Inc. Announces Pivotal Trial Success for Breast Cancer Locator System, Demonstrating Improved Surgical Outcomes Cairn Surgical, Inc., a medical technology innovator focused on improving precision in breast cancer surgery, has announced encouraging results from its pivotal clinical trial…

Read MoreCairn Surgical Announces Positive Pivotal Trial Results for Breast Cancer Locator System
FLEX

FLEX Study Highlights Biology-Driven Treatment Response Over Race in Basal-Type Breast Cancer Patients

Agendia Presents FLEX Study Data at ASBrS 2026 Showing Consistent MammaPrint + BluePrint Performance Across Diverse Basal-Type Breast Cancer Groups Agendia®, Inc., a recognized leader in precision oncology for breast cancer, has announced the presentation of new findings from its…

Read MoreFLEX Study Highlights Biology-Driven Treatment Response Over Race in Basal-Type Breast Cancer Patients
E-Scopics

E-Scopics Gains FDA Clearance for Hepatoscope® Upgrade with Advanced Liver Imaging, to Be Showcased at DDW 2026

E-Scopics Secures FDA Clearance for Enhanced Hepatoscope® Platform E-Scopics has announced a major advancement in liver disease diagnostics with the latest U.S. clearance from the U.S. Food and Drug Administration for its upgraded Hepatoscope platform. This milestone reflects the company’s…

Read MoreE-Scopics Gains FDA Clearance for Hepatoscope® Upgrade with Advanced Liver Imaging, to Be Showcased at DDW 2026
Contineum

Contineum Therapeutics Grants Equity Awards Under Nasdaq Rule 5635(c)(4)

Contineum Therapeutics, Inc. Reports Inducement Equity Grants Under Nasdaq Rule 5635(c)(4) Contineum Therapeutics a clinical-stage biopharmaceutical company focused on developing differentiated therapies for neuroscience, inflammation, and immunology (NI&I) indications, has announced the issuance of inducement equity awards to two newly…

Read MoreContineum Therapeutics Grants Equity Awards Under Nasdaq Rule 5635(c)(4)